Full Press Release Details
We are all numbers when it comes to eczema.
0-4 to be exact.
The ISGA, or Investigator’s Static Global Assessment , is a five-point scale that provides a clinical assessment of atopic dermatitis severity ranging from 0 to 4.
• 0 indicates clear
• 1 is almost clear
• 2 is mild
• 3 is moderate
• 4 indicates severe.
The lower the score, the better. A well-managed eczema patient is a patient at a 0-1 on the ISGA scale, and a successful therapy is typically regarded as one that safely and effectively reduces scores at least 2 points, ideally to an ISGA of 0-1. The length of time is very much product and study dependent; steroids are often evaluated over as little as 4 weeks while injectable biologics can be evaluated over 16 weeks.
As I like to teach via example, please see this public link for reference. Inside, you will see study results from a popular non-steroid topical indicated for mild to moderate eczema, or eczema that begins at an ISGA between 1 and 3.
Watch for more updates in the coming days. There’s a reason I’m teaching you this beyond just loving to create more educated patients, caregivers, and investors.